Beyond static structure: X-ray solution scattering: MAXS reveals a massive movement during catalytic action of the non-phosphorylated human kinase MAP2K4

MAXS extends traditional small-angle X-ray scattering by including scattering information from the middle-angle region (approximately q = 0.30–0.75 Å⁻¹). While conventional SAXS primarily provides overall molecular size and shape, MAXS also captures structural information related to distances between domains and secondary structural elements. This additional information enables analysis of conformational changes that occur within proteins while they remain in solution, providing greater insight into functional molecular motion.

Proteins are dynamic molecules that continually sample multiple conformations under physiological conditions. Crystal structures provide high-resolution snapshots but may be influenced by crystal packing and therefore represent only one possible structural state. Solution scattering techniques preserve native molecular flexibility, making it possible to observe structural transitions that regulate ligand binding, catalysis, and protein-protein interactions.

Rather than assuming a protein has a single structure, structural ensemble analysis models thousands of possible conformations and identifies combinations that best reproduce the experimental scattering data. This approach captures the distribution of structural states present in solution, including rare but functionally significant conformations that would be averaged out or overlooked by conventional modeling methods.

In solution, ATP binding causes MAP2K4 to adopt a more compact conformation than suggested by its crystal structure. The N-terminal and C-terminal lobes wrap more tightly around ATP, increasing overall structural stability while maintaining control over downstream phosphorylation events. Differential scanning calorimetry also demonstrated a substantial increase in thermal stability following ATP binding.

Binding of the substrate peptide increases flexibility within the N-terminal lobe while preserving an autoinhibited configuration through formation of a helical activation loop. This flexibility exposes phosphorylation sites for upstream kinases without allowing downstream substrates direct access to the ATP-binding site, providing a mechanism for controlled activation while preventing inappropriate signaling.

Crystal packing restricts molecular motion and can stabilize conformations that are not representative of the protein's natural behavior in solution. MAXS measurements showed that several structural features observed in crystals—including domain orientations and oligomeric arrangements—did not accurately reflect the dynamic conformational landscape present under solution conditions.

Instead of targeting only static binding pockets, dynamics-based drug design aims to stabilize or block specific conformational states that regulate protein activity. Potential approaches include preventing structural transitions required for ATP binding, increasing conformational instability to promote protein degradation, or locking proteins into inactive conformations. These strategies expand the range of possible therapeutic targets beyond those visible in conventional crystal structures.

MAXS complements techniques such as X-ray crystallography and cryo-electron microscopy by adding information about molecular motion in solution. When combined with structural ensemble modeling and other biophysical measurements, it provides a more complete understanding of how proteins function, regulate their activity, and respond to ligands, making it valuable for both fundamental biological research and structure-based drug development.